Co-Exclusive License to DPC for UBC Screening Technology Clause Samples

Co-Exclusive License to DPC for UBC Screening Technology. Except as set forth in Sections 2.6 and 2.7 hereof, and notwithstanding any provision of the Agreement to the contrary including, without limitation, Section 10.2.1 of the Agreement, Mitotix hereby grants DPC a co-exclusive (with Mitotix) worldwide royalty-free, fully paid-up right and license (with the right to sublicense) under the UBC Patent Rights, Mitotix Inventions, Joint Inventions and Know-how solely to utilize the UBC Targets and assays (including reagents and materials used in such assays) to identify compounds active against such UBC Targets for the purposes of research, development and commercialization of pharmaceutical and Radiopharmaceutical products incorporating such compounds for all therapeutic indications. No license is granted to DPC under this Section 2.4 to utilize the UBC Targets for Antisense, Gene Therapy and non-Radiopharmaceutical diagnostic applications.